Miao Z. Zheng
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Varicella and varicella zoster virus meningoencephalitis in a diffuse large B-cell lymphoma patient after chimeric antigen receptor-T-cell therapy.
Journal: The Journal of antimicrobial chemotherapy
Published: February 05, 2026
ATG Plus Post-Transplantation Cyclophosphamide Improves EBV-DNA Clearance and GVHD in Patients of Adult Chronic Active Epstein-Barr Virus Disease Undergoing Allogeneic HSCT.
Journal: Journal of blood medicine
Published: January 01, 2026
Central nervous system infections caused by carbapenem-resistant klebsiella pneumoniae after CAR T-cell therapy in a patient with preexisting colonization: a case report and literature review.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: July 22, 2025
CD19 chimeric antigen receptor T-cell therapy for the treatment of a patient with refractory Burkitt lymphoma after kidney transplant.
Journal: Cytotherapy
Published: June 02, 2025
Daratumumab for CD20-CD38+ Relapsed/Refractory Diffuse Large B-Cell Lymphoma.
Journal: Journal of cellular and molecular medicine
Published: May 15, 2025
Angioimmunoblastic T-cell lymphoma: a concise overview encompassing the pathogenetic, pathological, clinical, therapeutical characteristics, and recent advances.
Journal: Clinical and experimental medicine
Published: April 22, 2025
Amphiregulin: a potential therapeutic target for tissue fibrosis.
Journal: Trends in pharmacological sciences
Published: April 18, 2025
Efficacy and safety of zanubrutinib combined with chimeric antigen receptor T-cell therapy targeting CD19 in refractory or relapsed diffuse large B cell lymphoma: A retrospective analysis.
Journal: Cancer treatment and research communications
Published: December 10, 2024
Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL.
Journal: Blood cancer discovery
Published: November 18, 2024
The lncRNA LINC02446 promotes tumor progression and HLH occurrence by regulating the expression of KLRs and IL-10 in EBV-NK-LPDs.
Journal: International immunopharmacology
Published: November 03, 2024
Long-term outcomes in patients with persistent EBV-DNA positivity after primary Epstein-Barr virus infection and clinical implications of rituximab therapy.
Journal: International immunopharmacology
Published: July 24, 2024
Efficacy of programmed cell death 1 inhibitor maintenance after chimeric antigen receptor T cells in patients with relapsed/refractory B-cell non-Hodgkin-lymphoma.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 13, 2024
Last Updated: 09/26/2026